Ketogenic Diet: Separating Myths from Science-Backed Facts

Ketogenic myths vs facts — at a glance, here are the most important points to walk away with before you read the deep dive below.

• Nutritional ketosis (0.5–3.0 mmol/L) is a normal, controlled metabolic state and is physiologically distinct from diabetic ketoacidosis, which involves ketone levels of 15–25 mmol/L alongside dangerously high blood glucose. • Early rapid weight loss is mostly water from depleted glycogen; at 12–24 months, ketogenic and low-fat diets typically show no significant difference in fat loss, with adherence the real driver of outcomes. • The strongest evidence is for metabolic health — one 2019 trial found ketogenic dieters with type 2 diabetes cut HbA1c by 1.3% in a year, alongside 60% reducing their medication under supervision. • Triglycerides often drop 30–50% on keto and HDL typically rises, though LDL response is highly individual and can rise sharply in some people, warranting monitoring. • Keto flu (fatigue, headache, brain fog) in the first 1–2 weeks is caused by electrolyte loss, not illness, and usually resolves with more salt and potassium-rich foods. • People with type 1 diabetes, kidney disease, a history of eating disorders, or who are pregnant or breastfeeding should not attempt strict keto without medical supervision.

When carbohydrate intake drops below approximately 50 grams per day (for most people), glycogen stores in the liver are depleted within 24–48 hours — a state also achievable through extended intermittent fasting. Without glycogen to release glucose, the liver begins converting fatty acids into ketone bodies — primarily beta-hydroxybutyrate (BHB), acetoacetate, and acetone. These ketone bodies enter the bloodstream and are used as an alternative fuel source by the brain, heart, and skeletal muscle.

This metabolic state is called nutritional ketosis. It is distinct from diabetic ketoacidosis (DKA), which is a dangerous condition in which both blood glucose and ketones are extremely elevated simultaneously — typically in people with type 1 diabetes whose insulin production is absent. Nutritional ketosis in healthy individuals involves mild elevations of ketones (0.5–3.0 mmol/L) with normal or low blood glucose, and insulin is present (albeit at lower levels than in carbohydrate-fed states).

In ketosis, fatty acid oxidation increases substantially. The body becomes highly efficient at mobilising and burning stored fat. This metabolic shift is central to many of the claimed benefits of ketogenic diets — and to some of the challenges people experience during adaptation.

The ketogenic diet reliably produces rapid initial weight loss — often 2–5 kg in the first week. However, most of this is water weight. Glycogen stores approximately 3–4 grams of water per gram; depleting these stores releases substantial water. True fat loss begins after the first week.

In randomised controlled trials comparing ketogenic to low-fat diets over 6–12 months, ketogenic diets consistently show greater weight loss at 3 and 6 months. At 12 months, the difference narrows and is often statistically insignificant. At 24 months, many studies show no significant difference in weight outcomes between diet patterns.

The mechanism for superior short-term weight loss is debated. Some researchers attribute it to the appetite-suppressing effects of ketones and high protein intake (protein is the most satiating macronutrient). Others point to reduced food variety decreasing overall palatability and caloric intake. Others argue for a genuine metabolic advantage of fat oxidation. The scientific consensus leans towards the appetite and caloric restriction explanation rather than a unique fat-burning metabolic advantage.

Importantly, the best diet for weight loss is the one you can adhere to long-term. Adherence rates for ketogenic diets are lower than for more moderate approaches in most long-term studies — though this varies significantly by individual.

Where the ketogenic diet's evidence is most convincing is metabolic health — particularly type 2 diabetes and metabolic syndrome. Multiple clinical trials have shown that ketogenic diets produce significant reductions in HbA1c, fasting blood glucose, fasting insulin, and triglycerides in people with type 2 diabetes — in some cases enabling medication reduction under medical supervision.

The mechanism is direct: removing dietary carbohydrates reduces the post-meal glucose load that strains an insulin-resistant system. The pancreas is not required to release large amounts of insulin; blood glucose variability decreases; and improved insulin sensitivity follows as visceral fat is lost.

A 2019 study in the journal Diabetes Therapy found that a ketogenic dietary intervention in people with type 2 diabetes produced HbA1c reductions of 1.3% after one year — greater than many pharmaceutical agents — alongside significant weight loss and medication reduction in 60% of participants.

For triglycerides specifically, ketogenic diets are remarkably effective, often reducing levels by 30–50%. This is likely due to reduced carbohydrate-stimulated hepatic triglyceride synthesis. HDL cholesterol typically rises. LDL responses are more variable — some people see no change or modest rises, while others (particularly those genetically predisposed) experience dramatic LDL increases that require attention.

The ketogenic diet's oldest validated medical use is epilepsy treatment. Since the 1920s, it has been used in children with drug-resistant epilepsy, with roughly 50% of patients experiencing a 50% reduction in seizure frequency. The mechanism is not fully understood but likely involves reduced neuronal excitability from ketone metabolism and changes in GABA/glutamate balance.

For Alzheimer's disease and mild cognitive impairment, early research is intriguing. The brain's glucose metabolism is impaired in Alzheimer's — some researchers describe it as 'type 3 diabetes' — but neurons can still metabolise ketones. Pilot studies using medium-chain triglyceride (MCT) supplementation to induce mild ketosis have shown modest cognitive improvements in some patients. Larger RCTs are underway.

For healthy individuals, claims that ketosis dramatically enhances cognitive performance are not well supported by the current evidence. Some people report improved mental clarity during ketosis; others describe brain fog, particularly during adaptation. Individual variation is substantial.

**Myth: Ketosis burns fat constantly regardless of caloric intake.** False. Ketosis increases fat oxidation, but if you are eating more calories than you expend — even from fat — you will not lose fat. Ketone production and fat loss are related but not synonymous.

**Myth: Ketogenic diets destroy kidney function.** There is no good evidence that ketogenic diets impair kidney function in healthy individuals. People with pre-existing kidney disease should be cautious about high protein intake, but standard ketogenic diets are moderate (not high) in protein.

**Myth: Ketosis is dangerous because it's close to ketoacidosis.** Nutritional ketosis (0.5–3 mmol/L ketones) and diabetic ketoacidosis (15–25 mmol/L ketones with hyperglycaemia) are physiologically very different states. The comparison conflates two unrelated conditions.

**Myth: Ketogenic diets are the only effective way to lose weight.** Multiple dietary patterns produce effective weight loss. The ketogenic diet is one valid tool, particularly suited to people with insulin resistance or who find appetite suppression helpful. It is not uniquely superior for fat loss in people without metabolic dysfunction.

**Myth: You must stay in ketosis forever for the diet to work.** Cyclical approaches (periods of ketosis followed by moderate carbohydrate eating) are used by many people and may offer metabolic flexibility benefits.

For most healthy adults, ketogenic diets appear safe for periods of 6–24 months based on current evidence. Long-term data beyond two years remains limited, which is a genuine uncertainty that advocates should acknowledge.

Cardiac concerns centre on LDL cholesterol. While average LDL responses are modest, a subset of individuals — lean mass hyper-responders and those with familial hypercholesterolaemia — experience dramatic LDL elevations on high-fat diets. These individuals require monitoring and, potentially, dietary modification.

Bone density is a concern raised in some paediatric epilepsy studies, where prolonged strict ketogenic diets were associated with reduced bone mineral density. Whether this applies to adults is less clear.

Groups who should avoid strict ketogenic diets without medical supervision: people with type 1 diabetes (DKA risk), those with kidney disease, those with pancreatic insufficiency or fat malabsorption, pregnant or breastfeeding women, and anyone with a history of eating disorders.

The guidance in this article draws on peer-reviewed nutrition and food-science literature as well as guidance from major public-health bodies. Key reference sources we have consulted while writing and updating this piece include:

• Harvard T.H. Chan School of Public Health, *The Nutrition Source*, 2024. • U.S. National Institutes of Health (NIH), Office of Dietary Supplements, fact sheets, 2024. • World Health Organization (WHO), Healthy Diet fact sheet, 2024. • Cochrane Database of Systematic Reviews — relevant systematic reviews, 2020–2024. • British Dietetic Association (BDA) Food Fact Sheets, 2024.

These references are provided so that motivated readers can verify claims and explore the underlying evidence directly. Where a specific trial, meta-analysis, or named author is referenced in the body of the article, that citation takes precedence over the general sources listed here. The article is reviewed periodically against newly published evidence and updated when meaningful new findings emerge.